Condition
HPV Testing
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed2
Not Yet Recruiting1
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07214506Not ApplicableNot Yet Recruiting
Human Papillomavirus (HPV) Self-Sampling Options to Promote Equity
NCT02155231CompletedPrimary
Study on Anal Human Papillomavirus Infection and Anal Intraepithelial Neoplasia Among Men Who Have Sex With Men in Indonesia, Malaysia, and Thailand
NCT06644677Completed
Third-Generation Nanopore HPV Integration Site for Precise Prediction of Cervical Cancer Prognosis
NCT05727228Recruiting
Screening Triage and Risk Stratification
NCT02613611UnknownPrimary
HPV Screening (Human Papilloma Virus)
Showing all 5 trials